Elena Armenteros Monterroso

Elena Armenteros Monterroso

AstraZeneca, Sweden - Södertälje / Sweden
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1357885
-
person_outline Elena Armenteros Monterroso's MOST POPULAR ARTICLES
1-) The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancerMS Kumar, DC Hancock, M Molina-Arcas, M Steckel, P East, ...Cell 149 (3), 642-655, 20122892012
2-) Snail1 controls TGF-β responsiveness and differentiation of mesenchymal stem cellsR Batlle, L Alba-Castellón, J Loubat-Casanovas, E Armenteros, C Francí, ...Oncogene 32 (28), 3381-3389, 2013742013
3-) RAS mutation status and bortezomib therapy for relapsed multiple myelomaD Smith, E Armenteros, L Percy, M Kumar, A Lach, G Herledan, M Stubbs, ...British journal of haematology 169 (6), 905-908, 2015232015
4-) The AAA+ ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemiaE Armenteros-Monterroso, L Zhao, L Gasparoli, T Brooks, K Pearce, ...Leukemia 33 (12), 2817-2829, 2019252019
5-) Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47phox-Deficient Chronic Granulomatous DiseaseHuman Gene Therapy, 202152021